Clearstead Advisors, LLC Globus Medical Inc Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 330 shares of GMED stock, worth $27,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
330
Previous 543
39.23%
Holding current value
$27,868
Previous $32,000
43.75%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GMED
# of Institutions
551Shares Held
118MCall Options Held
279KPut Options Held
45.9K-
Vanguard Group Inc Valley Forge, PA10.6MShares$896 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$873 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.55MShares$638 Million0.21% of portfolio
-
Jpmorgan Chase & CO New York, NY3.68MShares$311 Million0.01% of portfolio
-
Sculptor Capital LP New York, NY3.5MShares$296 Million5.4% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $6.51B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...